DanCann Pharma A/S Alternatives & Competitors

12 companies similar to DanCann Pharma A/S — - a biopharmaceutical company powered by cannabinoids

Sanity Group

Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and consumer...

104 Convertible Note $131.80M

Berlin, Germany

Biotechnology Health Care +1

Avicanna Inc. (TSX:AVCN)

Driving biopharmaceutical advancements of plant-derived cannabinoid-based products.

67 Post-IPO Equity $27.06M

Toronto, Canada

Biotechnology Pharmaceutical

Lanthio Pharma

Biopharmaceutical company discovering and developing stabilized lanthipeptides in oncology...

1 Debt Financing $8.40M

Groningen, The Netherland...

Biotechnology Health and Wellness +1

InMed Pharmaceuticals

Global leader in the manufacturing and development of rare cannabinoids. Our subsidiary is...

18 Post-IPO Equity

Canada

Biotechnology Health Care +1

Rival Readout

Competing with DanCann Pharma A/S? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.

44 IPO $218.00M

Singapore, Singapore

Biotechnology Health Care +1

Oxford Cannabinoid Technologies Holdings Plc

A biotech company harnessing the therapeutic power of cannabinoids.

10 Post-IPO Debt $18.17M

Oxford, United Kingdom

Biotechnology Pharmaceutical

Sinceritas EU

🇩🇪 • EU-GMP Manufacturer of Cannabis Flowers & Extracts

Skopje, Macedonia

Manufacturing Pharmaceutical

KeifeRx

KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...

7 Series A $6.00M

Mclean, United States

Biopharma Biotechnology +1

Helioson

A biopharmaceutical pioneer dedicated to creating groundbreaking therapies for cancer.

Seed $10.00M

Biopharma Biotechnology +1

Taibang Biological Group

Offering comprehensive development, manufacture, and sale of plasma-derived and biopharmac...

Private Equity $899.55M

Biopharma Biotechnology +2

Teewinot Life Sciences

Teewinot is a global leader in the biosynthetic development and production of cannabinoids...

2 Series B $19.30M

Tampa, United States

Biotechnology Pharmaceutical

GESLabs

Leading Naturally

London, United Kingdom

Biotechnology Health and Wellness +1

About DanCann Pharma A/S

Dancann Pharma is a biopharmaceutical company based in Denmark, focusing on utilizing the potential of cannabinoids in the medical field. Founded in 2018, the company is at the forefront of the intersection between Biotechnology, Manufacturing, and Pharmaceutical industries. In November 2023, Dancann Pharma secured a s...

Business keywords

Biopharmaceutical, Cannabinoids, Pharmaceutical Research, Medical Cannabis

Frequently Asked Questions

Companies similar to DanCann Pharma A/S include Sanity Group, Avicanna Inc. (TSX:AVCN), Lanthio Pharma, InMed Pharmaceuticals, ASLAN Pharmaceuticals. They work in Biotechnology and Pharmaceutical and share DanCann Pharma A/S's focus on cannabinoids, biopharmaceutical and pharmaceutical research.

Bounce Watch lists 12 companies that share DanCann Pharma A/S's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around DanCann Pharma A/S: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

DanCann Pharma A/S Profile Sanity Group Alternatives Avicanna Inc. (TSX:AVCN) Alternatives Lanthio Pharma Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at DanCann Pharma A/S on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.